Making NMO History – NMO Patient Day 2015
Katja Van Herle: I’d like to start by welcoming you all to the home of NMO. Victoria Jackson: A lot of what happens in research is people work in all…
Michael Levy, MD, phD – Johns Hopkins University: The short answer is yes. The long answer is we don’t know how that happens. For the most part, after a patient…
Sean Pittock, MD – Mayo Clinic: Since the discovery of the aquaporin-4 antibody in 2004 the spectrum of NMO has dramatically changed and evolved to what we now consider NMO…
James Bowen, MD – MS Center, Swedish Neuroscience Institute: In NMO, the immune system is too active, so all of our treatments are really directed at decreasing the immune system…
Marios Papadopoulos, MD – St. George’s University of London: Does spinal cord damage occur in NMO? Spinal cord damage occurs in all patients with NMO, because it’s one of the…